drugset / Trial / NCT02158624
Ranibizumab Treatment for Age-Related Macular Degeneretion
Unknown
100 enrolled
Kyushu University
Clinical Research Support Center Kyush · collabFukuoka University · collabKurume University · collabNovartis · collabUniversity of Occupational and Environmental Health · collab
NaSingle-groupOpen-labelTreatment
Summary
To establish the correlation between visual acuity improvement and QOL measurement after ranibizumab treatment for AMD patients.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-04
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |